Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Myocardial blush grade (mbg) is not altered by microvasculopathy or acute rejection (ar) occurring early after orthotopic heart transplantation (OHT)

M Zakliczyński, A Lekston, D Konecka-Mrówka, J Nożyński, D Trybunia, Ł Pyka, M Świerad, R Przybylski, M Zembala

Ann Transplant 2009; 14(1): 65-65 :: ID: 880438

Abstract

Background: A relation between microvasculopathy observed in endomyocardial biopsies (EMBs) and clinical coronary vasculopathy (CAV) after OHT remains controversial. Aim of the study was to find a potential relation between microvasculopathy features and AR observed early after OHT and MBG.
Material/Methods: We performed a retrospective analysis of early coronary
angiographies (performed between 4th and 6th week after OHT) from 55 subjects. Based on MBG analysis we identifi ed a group of six pts. with decreased MBG (6M, 52±7y/o, ischemic c-pathy in 50%), that was confronted with a group of 49 pts. with normal MBG (43M/6F, 45±12y/o, ischemic c-pathy in 39%). Microvasculopathy was assessed using the following features: presence of prominent endothelial cells, degeneration of the endothelium, thickening of the muscle layer, thickening of the vascular wall (basal membrane and muscle layer), presence of lymphocytes in the arteriolar wall with-out any other signs of rejection vasculitis, periarteriolar fibrosis, and an occluded arteriolar lumen.
Results: Significant AR was observed in 17 vs. 10% of pts. with decreased and normal MBG, respectively. All microvasculopathy features, except presence of prominent endothelial cells and periarteriolar fibrosis, were more frequent in pts. with normal MBG. None of the differences was statistically significant.
Conclusions: MBG is not influenced by AR or microvasculopathy features observed early after OHT.

Keywords: Heart Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358